Phase 3 Study to Evaluate the Safety and Efficacy of Galnobax® in Treating Diabetic Foot Ulcers
Clinical trial NCT03998436 · COMPLETED
Trial details
- NCT number
- NCT03998436
- Sponsor
- Novalead Pharma Private Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-26
- Primary completion
- 2021-08-19
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.